Almaghrabi, 2013 - Google Patents
Isolation and characterisation of bacteriophages that infect capsulated Streptococcus pneumoniaAlmaghrabi, 2013
View PDF- Document ID
- 17399106947403587329
- Author
- Almaghrabi M
- Publication year
External Links
Snippet
S. pneumoniae (pneumococcus) is a major cause of pneumonia, sepsis, and meningitis, responsible for over 1.2 million deaths per year. Rates of antibiotic resistance are rising, with over one third of isolates in the US and parts of Europe showing a reduced susceptibility to …
- 238000002955 isolation 0 title abstract description 58
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2795/00—Bacteriophages
- C12N2795/00011—Bacteriophages
- C12N2795/10011—Bacteriophages dsDNA Bacteriophages
- C12N2795/10041—Use of virus, viral particle or viral elements as a vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2795/00—Bacteriophages
- C12N2795/00011—Bacteriophages
- C12N2795/00032—Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Micro-organisms or materials therefrom
- A61K35/76—Viruses; Subviral particles; Bacteriophages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Micro-organisms or materials therefrom
- A61K35/74—Bacteria
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Hybridisation probes
- C12Q1/6888—Hybridisation probes for detection or identification of organisms
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Jamalludeen et al. | Isolation and characterization of nine bacteriophages that lyse O149 enterotoxigenic Escherichia coli | |
KR101761578B1 (en) | Novel enteropathogenic Escherichia coli bacteriophage Esc-CHP-2 and its use for preventing proliferation of enteropathogenic Escherichia coli | |
CN112063594B (en) | High-temperature-resistant salmonella bacteriophage RDP-SA-18056 and preparation process of microcapsules thereof | |
CN108699531B (en) | Pasteurella multocida bacteriophage Pas-MUP-1 and application thereof in inhibiting proliferation of Pasteurella multocida | |
KR101261873B1 (en) | Bacteriophage having bacteriocidal effect on Salmonella spp., the cause of sitotoxism | |
Ma et al. | Isolation and identification of a bacteriophage capable of infecting Streptococcus suis type 2 strains | |
Rao et al. | First report on genetic characterization, cell‐surface properties and pathogenicity of Lactococcus garvieae, emerging pathogen isolated from cage‐cultured cobia (Rachycentron canadum) | |
CN108699532B (en) | Vibrio parahaemolyticus bacteriophage Vib-PAP-2 and use thereof for inhibiting proliferation of Vibrio parahaemolyticus | |
CN113164537B (en) | Therapeutic phage | |
JP2024523382A (en) | Bacteriophages against vancomycin-resistant enterococci | |
Letarov et al. | Ecological basis for rational phage therapy | |
CN117286117A (en) | Broad-spectrum salmonella phage SalmpYZU33 and application thereof | |
CN113583966A (en) | Salmonella furciosus bacteriophage and application thereof | |
CN113166730B (en) | Novel streptococcus suis bacteriophage STR-SUP-1 and use thereof in inhibiting streptococcus suis bacterial proliferation | |
KR101581654B1 (en) | Method for prevention and treatment of Escherichia coli Type K99 | |
CN112437810A (en) | Novel streptococcus suis bacteriophage STR-SUP-2 and application thereof in inhibiting streptococcus suis bacterial proliferation | |
Tee et al. | A newly isolated Pseudomonas otitidis phage, vB_PotS-PotUPM1 from tilapia in Malaysia | |
US20210161978A1 (en) | Novel streptococcus suis bacteriophage str-sup-3, and use thereof for inhibiting proliferation of streptococcus suis strains | |
Almaghrabi | Isolation and characterisation of bacteriophages that infect capsulated Streptococcus pneumonia | |
KR102673134B1 (en) | Composition for inhibiting proliferation of Salmonella enteritidis comprising bacteriophage | |
Gichuhi | Diversity of Vibrio Cholerae Bacteriophages From Lake Victoria, Coastal and Central Regions of Kenya and Assessment Of Their Potential as Bio Control Agents Against the Pathogen | |
CN118581050B (en) | Salmonella phage vB-SenS-JZ291 and application thereof | |
Sabri et al. | Isolation, Characterization and Genomic Analysis of a Novel Lytic Bacteriophage PAT1 Infecting Agrobacterium tumefaciens | |
EP2887949A1 (en) | Therapeutic bacteriophages | |
Muscat | Investigation of Rhodococcus equi bacteriophages from Australian horse breeding farms |